Andere talen Vivozon Pharmaceutical Co., Ltd.

Aandelen

A082800

KR7082800004

slotkoers Korea S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.840 ^KRW	-0,35%		-2,07%	-5,33%

2023	Vivozon Pharmaceutical Co, Ltd. (KOSDAQ:A082800) kondigt een aandeleninkoop aan voor KRW 5 miljoen aan aandelen.	CI
2023	Vivozon Pharmaceutical Co., Ltd. keurt een terugkoopplan goed.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tranche Update on Vivozon Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 19, 2023.	21-09-23
Vivozon Pharmaceutical Co., Ltd.'s Equity Buyback announced on September 19, 2023, has closed with 5,000,000 shares.	20-09-23
Vivozon Pharmaceutical Co., Ltd. announces an Equity Buyback for 5,000,000 shares.	19-09-23
Vivozon Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	19-09-23
Vivozon Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Vivozon Pharmaceutical Co., Ltd. announced that it has received KRW 2.000000072 billion in funding	28-02-23
Vivozon Pharmaceutical Co., Ltd. announced that it expects to receive KRW 2.000000072 billion in funding	09-01-23
Vivozon Pharmaceutical Co., Ltd. announced that it has received KRW 6 billion in funding	20-12-22
Vivozon Healthcare, Inc. announced that it expects to receive KRW 6 billion in funding	11-11-22
Vivozon Healthcare, Inc.(KOSDAQ:A082800) dropped from S&P Global BMI Index	26-08-22
Vivozon Healthcare, Inc. announced that it has received KRW 58.171164251 billion in funding from Vaultea, Inc. and other investors	05-04-22
Vivozon Healthcare, Inc. announced that it expects to receive KRW 58.171164251 billion in funding from Vaultea, Inc. and other investors	25-03-22
Vivozon Healthcare, Inc. announced that it has received KRW 10 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd.	17-12-21
Vivozon Healthcare, Inc. announced that it expects to receive KRW 10 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd.	10-05-21
Osung Advanced Materials Co., Ltd. cancelled the acquisition of Rumi Technology & Loan CO.,LTD. from Lumimicro Co., Ltd for KRW 33.7 billion.	17-01-21
December Fund 3, Nikkei Fund 3 and Pureun Fund 1 cancelled the acquisition of 23.85% stake in Lumimicro Co., Ltd from Osung Advanced Materials Co., Ltd. and S-MAC CO., Ltd..	18-11-20
Vivozon Healthcare, Inc. announced that it has received KRW 30 billion in funding from Korea Fixed-Income Investment Advisory, Korea Bond Investment Advisory Co., Ltd.	05-11-20
Lumimicro Co., Ltd completed the acquisition of 85.78% stake in Inist Bio Co.,Ltd. from Inistpharm Co.,Ltd, Kim, Kook-Hyun, Park, Ji-seop, Industrial Bank of Korea and others.	30-09-20
Lumimicro Co., Ltd agreed to acquire 85.78% stake in Inist Bio Co.,Ltd. from Inistpharm Co.,Ltd, Kim, Kook-Hyun, Park, Ji-seop, Industrial Bank of Korea and others for KRW 60.9 billion.	23-09-20
Vivozon Healthcare, Inc.(KOSDAQ:A082800) added to S&P Global BMI Index	21-09-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Vivozon Pharmaceutical Co., Ltd.

Aandelen

A082800

KR7082800004

Andere talen

Filters